Combination of immunotherapy and VEGF inhibitor improves survival in hepatocellular carcinoma
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall…
Browsing: VEGF inhibitor
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Colourless, odorless gas likely linked to alarming rise in non-smoking lung cancer
- ANZUP’s ENZA-p combination breakthrough for patients with metastatic castration-resistant prostate cancer
- Lung cancer does not decrease in line with reduced smoking
- Assessment of clinical benefit in recent FDA accelerated approvals for cancer drugs
- Opening a new front against pancreatic cancer
- AACR 2024: Adagrasib plus cetuximab may provide clinical benefit in patients with KRASG12c-mutated colorectal cancer
- Virtual reality sessions lessen cancer pain in clinical trial
- AACR 2024: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects